Desloratadine nitric oxide donor, and preparation method and application thereof

A compound and pharmaceutical technology, applied in the field of medicine, can solve problems such as damage, mutagenesis, and side effects

Inactive Publication Date: 2015-01-21
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chemotherapy is faster, but the cure rate is very low
At the same time, it is clinically found that many anticancer drugs have obvious damage and side effects on the normal body, such as mutagenesis and genotoxicity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Desloratadine nitric oxide donor, and preparation method and application thereof
  • Desloratadine nitric oxide donor, and preparation method and application thereof
  • Desloratadine nitric oxide donor, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Preparation of intermediate Ⅲ-1

[0038]

[0039] Add desloratadine (II, 10g, 32mmol) into the reaction flask equipped with stirring, thermometer and condenser, add toluene (50mL) and stir to make it dissolve, add sodium bicarbonate (5.4g, 64mmol), and keep at 20°C Stir under low pressure, add 2-chloropropionyl chloride (Ⅲ-1, 4.8g, 38mmol) dropwise, keep the temperature and stir for 2h, TLC detection shows that the reaction is complete (developing agent ethyl acetate:petroleum ether=1:3).

[0040] Filter the reaction solution to remove solid insoluble matter, pour the filtrate into 100ml of cold water, shake and separate the layers, separate the organic layer, and wash with water three times in succession. The organic layer was dried over anhydrous sodium sulfate and left overnight. After filtration, the solvent was evaporated to dryness under reduced pressure to obtain a light yellow solid. The resulting product was purified by silica gel column chromatography to ...

Embodiment 2

[0042]

[0043] Add desloratadine (II, 10g, 32mmol) into a reaction flask equipped with stirring, thermometer and condenser, add acetone (50mL) and stir to make it dissolve, add sodium hydroxide (2.6g, 64mmol), 0°C Stir under low pressure, add dropwise 4-chlorobutyryl chloride (Ⅲ-2, 5.1g, 36mmol), keep the temperature and stir for 2h, TLC detection shows that the reaction is complete (developing agent ethyl acetate:petroleum ether=1:3).

[0044] The reaction solution was filtered to remove solid insolubles, and the filtrate was poured into 200ml of cold water, stirred, and solids were precipitated. Filter, wash the filter cake with water, and dry to obtain a crude yellow solid. The crude product was recrystallized from ethanol to obtain 9.7 g of white solid. The purity is 96.9% (HPLC normalization method), and the yield is 72.7%. ESI-MS (m / z): 415.1.

Embodiment 3

[0046]

[0047] Add desloratadine (II, 10g, 32mmol) into the reaction flask equipped with stirring, thermometer and condenser, add pyridine (50mL), stir to dissolve, stir at 0°C, add 2-chloroethyl Sulfonyl chloride (Ⅲ-3, 5.9g, 36mmol), keep the temperature and stir for 3h, TLC detection shows that the reaction is complete (developer ethyl acetate:petroleum ether=1:3).

[0048] The reaction solution was poured into 200ml of cold water, stirred, and solids were precipitated. After filtering, the filter cake was washed with water and dried to obtain a brownish yellow solid crude product. The crude product was recrystallized from ethanol to obtain 8.9 g of off-white solid. The purity is 98.2% (HPLC normalization method), and the yield is 63.8%. ESI-MS (m / z): 437.1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and discloses a desloratadine nitric oxide donor with novel structure shown as a formula I and pharmaceutically acceptable salts thereof, wherein X is carbonyl or sulfonyl, n equals to 0, 1 or 2, and R is hydrogen and C1-C4 alkyl. The invention also relates to a preparation of the compound, and also discloses a pharmaceutical composition using the compound or the pharmaceutically acceptable salt thereof as an active ingredient, and application thereof as antitumor drug, especially application thereof to preparation of drugs for the treatment of breast cancer, lung cancer and stomach cancer.

Description

technical field [0001] The invention belongs to the technical field of medicine, more specifically, relates to a class of compounds with anti-tumor effect and their preparation method and application. Background technique [0002] Cancer has become a major chronic disease that seriously endangers human health. According to statistics, there are 9 million people who suffer from cancer every year in the world, and 6 million patients die from cancer. Almost one cancer patient dies every second. The annual incidence of cancer in my country is about 1.2 million, the number of cancer deaths is as high as more than 900,000, and the number of patients waiting for treatment exceeds 1.5 million, and there is an increasing trend year by year. Therefore, cancer has become the second largest killer after cardiovascular disease. Clinically, tumors are treated in three major ways: surgery, radiotherapy, and chemotherapy. Although the chemotherapy method is quicker, the cure rate is very...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/04A61K31/4545A61P35/00
CPCC07D401/04
Inventor 李兴伟张远崔莹黄淑云
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap